Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
Brito, Juan P. , Sangaralingham, Lindsey R. , Graham, David J. , Wang, Zhong , Wu, Yute, Smallridge, Robert C., Bernet, Victor , Shah, Nilay D. , Sangaralingham, Lindsey, Yao, Xiaoxi , Brito, Juan P , Ross, Joseph S. , Dutcher, Sarah K. , Lipska, Kasia J.

Mayo Clinic

JAMA Network Open | September 30, 2020 | Volume: 3 | Issue: 9 | Pages: e2017645

10.1001/jamanetworkopen.2020.17645 | PMID 32997127 Get It

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Agathangelidis, Andreas , Chatzidimitriou, Anastasia , Gemenetzi, Katerina , Giudicelli, Véronique , Karypidou, Maria, Plevová, Karla , Davis, Zadie , Yan, Xiao‐Jie , Jeromin, Sabine , Schneider, Christof , Pedersen, Lone Bredo , Tschumper, Renee C. , Sutton, Lesley‐Ann, Gastel, Ellen J. van, Armand, Marine , Tausch, Eugen , Baer, Constance , Navarro, Alba , Septenville, Anne Langlois de, Guido, Valentina, Mitterbauer‐Hohendanner, Gerlinde, Brieghel, Christian , Lawless, Sarah, Meggendorfer, Manja , Brázdilová, Kamila, Ritgen, Matthias , Facco, Monica , Tresoldi, Cristina , Visentin, Andrea , Patriarca, Andrea , Catherwood, Mark , Bonello, Lisa, Sudarikov, Andrey , Roumelioti, Maria, Francová, Hana Skuhrová, Moysiadis, Theodoros , Giannopoulos, Krzysztof , Mansouri, Larry, Karan-Djurašević, Teodora , Sandaltzopoulos, Raphael , Fais, Franco , Kater, Arnon P. , Panovska, Irina, Rossi, Davide , Alshemmari, Salem , Costeas, Paul , Espinet, Blanca , Antić, Darko , Foroni, Letizia, Montillo, Marco , Trentin, Livio , Stavroyianni, Niki, Gaïdano, Gianluca , Celle, Paola Francia di, Niemann, Carsten Utoft , Anagnostopoulos, Αchilles , Pott, Christiane , Fischer, Kirsten , Hallek, Michael , Oscier, David , Jelinek, Diane F., Lefranc, Marie‐Paule , Belessi, Chrysoula, Davi, Frédéric , Rosenquist, Richard , Σταματόπουλος, Κώστας , Jelinek, Diane, Gaidano, Gianluca , Rosenquist, Richard , Espinet, Blanca , Baliakas, Panagiotis , Scarfò, Lydia , Biderman, Bella V. , Bagnara, Davide , Guido, Valentina, Dimovski, Aleksandar J , Vanura, Katrina , Veronese, Silvio , Bödör, Csaba , Panagiotidis, Panagiotis T. , Campo, Elı́as , Stilgenbauer, Stephan , Haferlach, Claudia , Chiorazzi, Nicholas , Pospı́šilová, Šárka , Kossida, Sofia , Langerak, Anton W. , Ghia, Paolo

Mayo Clinic

Blood | September 29, 2020 | Volume: 137 | Issue: 10 | Pages: 1365-1376

10.1182/blood.2020007039 | PMID 32992344 Get It

Abstract Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR immunoglobulin stereotypy in CLL has important implications for understanding disease pathophysiology and refining clinical decision-making. Nevertheless, several issues remain open, especially pertaining to the actual frequency of BcR immunoglobulin stereotypy and major subsets, as well as the existence of higher-order connections between individual subsets. To address these issues, we investigated clonotypic IGHV-IGHD-IGHJ gene rearrangements in a series of 29 856 patients with CLL, by far the largest series worldwide. We report that the stereotyped fraction of CLL peaks at 41% of the entire cohort and that all 19 previously identified major subsets retained their relative size and ranking, while 10 new ones emerged; overall, major stereotyped subsets had a cumulative frequency of 13.5%. Higher-level relationships were evident between subsets, particularly for major stereotyped subsets with unmutated IGHV genes (U-CLL), for which close relations with other subsets, termed “satellites,” were identified. Satellite subsets accounted for 3% of the entire cohort. These results confirm our previous notion that major subsets can be robustly identified and are consistent in relative size, hence representing distinct disease variants amenable to compartmentalized research with the potential of overcoming the pronounced heterogeneity of CLL. Furthermore, the existence of satellite subsets reveals a novel aspect of repertoire restriction with implications for refined molecular classification of CLL.
Increased body mass index is associated with decreased imaging quality of point‐of‐care abdominal aortic ultrasonography
Jeeji, Archana K., Ekstein, Samuel F. , Ifelayo, Oluwatomilona I., Oyemade, Kafayat A. , Tawfic, Sarah, Hyde, Robert J. , Laughlin, Michael J., Lohse, Christine M. , Kummer, Tobias , Bellamkonda, Venkatesh R. , Ifelayo, Oluwatomilona , Tawfic, Sarah S, Bellamkonda, Venkatesh R , Mullan, Aidan F.

Mayo Clinic

Journal of Clinical Ultrasound | September 28, 2020 | Volume: 49 | Issue: 4 | Pages: 328-333

10.1002/jcu.22929 | PMID 32984964 Get It

AbstractBackgroundGiven that abdominal aorta is a retroperitoneal structure, increased body mass index (BMI) may have an adverse effect upon the quality of aortic ultrasonographic imaging.PurposeTo assess the hypothesis that increased BMI is associated with worsening point‐of‐care abdominal aortic ultrasonographic image quality.MethodsThis is a retrospective single‐center study of point‐of‐care abdominal aortic ultrasound examinations performed in an academic emergency department (ED) with fellowship‐trained emergency ultrasonography faculty performing quality assurance review.ResultsMean ± SD BMI was 27.4 ± 6.2, among the 221 included records. The overall quality rating decreased as BMI increased (correlation coefficient − 0.24; P < .001) and this persisted after adjustment for age and sex (P < .001). Although BMI was higher on average in the records that were of insufficient quality for clinical decisions when compared with those of sufficient quality (mean BMI 28.7 vs 27.0), this did not reach statistical significance in a univariable setting (P = .11) or after adjusting for age and sex (P = .14).ConclusionThis study data shows a decrease in point‐of‐care abdominal aorta ultrasound imaging quality as BMI increases, though this difference did not result in a statistically significant impairment in achieving the minimum quality for clinical decisions. This finding may help ameliorate some clinician concerns about ultrasonography for patients with high BMI.
Body position does not influence muscle oxygenation during submaximal cycling
Wiggins, Chad C. , Shepherd, John R. A. , Joyner, Michael J. , Dominelli, Paolo B. , Wiggins, Chad C , Joyner, Michael J , Baker, Sarah E. , Uchida, Kôji

Mayo Clinic

Translational Sports Medicine | September 26, 2020 | Volume: 4 | Issue: 2 | Pages: 193-203

10.1002/tsm2.202 Get It

Sex differences in integrated neurocardiovascular control of blood pressure following acute intermittent hypercapnic hypoxia
Jacob, Dain W. , Ott, Elizabeth P., Scruggs, Zachariah M., Ivie, Clayton L., Harper, Jennifer L. , Limberg, Jacqueline K. , Baker, Sarah E. , Manrique‐Acevedo, Camila

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | September 23, 2020 | Volume: 319 | Issue: 6 | Pages: R626-R636

10.1152/ajpregu.00191.2020 | PMID 32966122 Get It

Repetitive hypoxic apneas, similar to those observed in sleep apnea, result in resetting of the sympathetic baroreflex to higher blood pressures (BP). This baroreflex resetting is associated with hypertension in preclinical models of sleep apnea (intermittent hypoxia, IH); however, the majority of understanding comes from males. There are data to suggest that female rats exposed to IH do not develop high BP. Clinical data further support sex differences in the development of hypertension in sleep apnea, but mechanistic data are lacking. Here we examined sex-related differences in the effect of IH on sympathetic control of BP in humans. We hypothesized that after acute IH we would observe a rise in muscle sympathetic nerve activity (MSNA) and arterial BP in young men ( n = 30) that would be absent in young women ( n = 19). BP and MSNA were measured during normoxic rest before and after 30 min of IH. Baroreflex sensitivity (modified Oxford) was evaluated before and after IH. A rise in mean BP following IH was observed in men (+2.0 ± 0.7 mmHg, P = 0.03), whereas no change was observed in women (−2.7 ± 1.2 mmHg, P = 0.11). The elevation in MSNA following IH was not different between groups (4.7 ± 1.1 vs. 3.8 ± 1.2 bursts/min, P = 0.65). Sympathetic baroreflex sensitivity did not change after IH in either group ( P > 0.05). Our results support sex-related differences in the effect of IH on neurovascular control of BP and show that any BP-raising effects of IH are absent in young women. These data enhance our understanding of sex-specific mechanisms that may contribute to BP changes in sleep apnea.
Loci identified by a genome‐wide association study of carotid artery stenosis in the eMERGE network
Palmer, Melody R. , Kim, Daniel Seung , Crosslin, David R. , Stanaway, Ian B. , Rosenthal, Elisabeth A. , Cronkite, David , Gordon, Allan , Du, Xiaomeng, Li, Yatong K., Feng, QiPing , Li, Rongling, Håkonarson, Håkon , Fasel, David , Sohn, Sunghwan , Sleiman, Patrick , Handelman, Samuel K. , Speliotes, Elizabeth K. , Larson, Eric B. , Jarvik, Gail P. , Jarvik, Gail P , Hakonarson, Hakon , Gordon, Adam S , Feng, Qiping , Carrell, David , Williams, Marc S , Weng, Chunhua , Pendergrass, Sarah A. , Kullo, Iftikhar J.

Mayo Clinic

Genetic Epidemiology | September 23, 2020 | Volume: 45 | Issue: 1 | Pages: 4-15

10.1002/gepi.22360 | PMID 32964493 Get It

AbstractCarotid artery atherosclerotic disease (CAAD) is a risk factor for stroke. We used a genome‐wide association (GWAS) approach to discover genetic variants associated with CAAD in participants in the electronic Medical Records and Genomics (eMERGE) Network. We identified adult CAAD cases with unilateral or bilateral carotid artery stenosis and controls without evidence of stenosis from electronic health records at eight eMERGE sites. We performed GWAS with a model adjusting for age, sex, study site, and genetic principal components of ancestry. In eMERGE we found 1793 CAAD cases and 17,958 controls. Two loci reached genome‐wide significance, on chr6 in LPA (rs10455872, odds ratio [OR] (95% confidence interval [CI]) = 1.50 (1.30–1.73), p = 2.1 × 10−8) and on chr7, an intergenic single nucleotide variant (SNV; rs6952610, OR (95% CI) = 1.25 (1.16–1.36), p = 4.3 × 10−8). The chr7 association remained significant in the presence of the LPA SNV as a covariate. The LPA SNV was also associated with coronary heart disease (CHD; 4199 cases and 11,679 controls) in this study (OR (95% CI) = 1.27 (1.13–1.43), p = 5 × 10−5) but the chr7 SNV was not (OR (95% CI) = 1.03 (0.97–1.09), p = .37). Both variants replicated in UK Biobank. Elevated lipoprotein(a) concentrations ([Lp(a)]) and LPA variants associated with elevated [Lp(a)] have previously been associated with CAAD and CHD, including rs10455872. With electronic health record phenotypes in eMERGE and UKB, we replicated a previously known association and identified a novel locus associated with CAAD.
Circulating CD14+HLA‐DRlo/− monocytic cells as a biomarker for epithelial ovarian cancer progression
Stenzel, Ashley E. , Abrams, Scott I. , Joseph, Janine M. , Goode, Ellen L. , Tario, Joseph D. , Wallace, Paul K. , Kaur, Divjot , Adamson, Anna‐Kay, Buas, Matthew F. , Lugade, Amit A., Laslavic, Angela , Orr, Brian , Odunsi, Kunle , Etter, John Lewis , Moysich, Kirsten B. , Moysich, Kirsten , Buas, Matthew F , Kaur, Divjot, Taylor, Sarah E , Edwards, Todd , Elishaev, Esther , Mongiovi, Jennifer M. , Winham, Stacey J. , Kaufmann, Scott H. , Modugno, Francesmary

Mayo Clinic

American Journal of Reproductive Immunology | September 22, 2020 | Volume: 85 | Issue: 3 | Pages: No page available

10.1111/aji.13343 | PMID 32905653 Get It

AbstractProblemPrevious studies identified circulating CD14+HLA‐DRlo/− monocytic cells as an immune suppressive subset in solid malignancies, such as prostate, renal cell carcinoma, and pancreatic cancer. Such monocytic cells have been implicated not only in tumour progression but also as a potential barrier for immunotherapy. This study examined the relationship between the frequency of circulating monocytic cells and epithelial ovarian cancer (EOC) progression pre‐ and post‐frontline chemotherapy, defined by disease stage, which is a leading prognostic factor for this malignancy.Method of studyIncident cases of 236 women with EOC were recruited and comprehensive flow cytometry was utilized to assess the frequency of peripheral blood CD33+CD11b+HLA‐DR−/lowCD14+CD15− monocytic cells, henceforth termed CD14+HLA‐DRlo/− monocytic cells, prior to and after completion of frontline chemotherapy. Multivariable odds ratios (OR) were used to estimate the association between CD14+HLA‐DRlo/− monocytic cell percentages and disease stage. Wilcoxon signed‐rank tests evaluated changes in these monocytic cell levels pre‐ and post‐chemotherapy in a patient subset (n = 70).ResultsPatients with elevated frequencies of circulating CD14+HLA‐DRlo/− monocytic cells at diagnosis were at 3.33‐fold greater odds of having advanced stage (III/IV) EOC (CI: 1.04‐10.64), with a significant trend in increasing CD14+HLA‐DRlo/−monocytic cell levels (P = .04). There was a 2.02% median decrease of these monocytic cells post‐chemotherapy among a subset of patients with advanced stage disease (P < .0001).ConclusionThese findings support the potential clinical relevance of CD14+HLA‐DRlo/−monocytic cells in EOC for prognosis and may indicate a non‐invasive biomarker to measure disease progression.
Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
Innocenti, Federico , Sibley, Alexander B. , Patil, Sushant, Etheridge, Amy S. , Jiang, Chen , Ou, Fang‐Shu , Howell, Stefanie , Plummer, Sarah J. , Bertagnolli, Monica M. , McLeod, Howard L. , Auman, J. Todd , Blanke, Charles D. , Furukawa, Yoichi , Kubo, Michiaki , Lenz, Heinz‐Josef , Ratain, Mark J. , Owzar, Kouros , Bertagnolli, Monica M , McLeod, Howard L , Auman, James T , Furukawa, Yoichi , Venook, Alan P , Kubo, Michiaki , Lenz, Heinz-Josef , Parker, Joel S , Ou, Fang-Shu , Casey, Graham , Venook, Alan P. , Parker, Joel S.

Mayo Clinic

Clinical Cancer Research | September 21, 2020 | Volume: 27 | Issue: 1 | Pages: 267-275

10.1158/1078-0432.ccr-20-2021 | PMID 32958699 Get It

Abstract Purpose: Irinotecan/5-fluorouracil (5-FU; FOLFIRI) or oxaliplatin/5-FU (FOLFOX), combined with bevacizumab or cetuximab, are approved, first-line treatments for metastatic colorectal cancer (mCRC). We aimed at identifying germline variants associated with survival in patients with mCRC treated with these regimens in Cancer and Leukemia Group B/SWOG 80405. Experimental Design: Patients with mCRC receiving either FOLFOX or FOLFIRI were randomized to either cetuximab or bevacizumab. DNA from peripheral blood was genotyped for approximately 700,000 SNPs. The association between SNPs and overall survival (OS) was tested in 613 patients of genetically estimated European ancestry using Cox proportional hazards models. Results: The four most significant SNPs associated with OS were three haplotypic SNPs between microsomal glutathione S-transferase 1 (MGST1) and LIM domain only 3 (LMO3, representative HR, 1.56; P = 1.30 × 10−6), and rs11644916 in AXIN1 (HR, 1.39, P = 4.26 × 10−6). AXIN1 is a well-established tumor suppressor gene in colorectal cancer, and rs11644916 (G&gt;A) conferred shorter OS. Median OS for patients with the AA, AG, or GG genotypes was 18.4, 25.6, or 36.4 months, respectively. In 90 patients with stage IV colorectal cancer from The Cancer Genome Atlas (TCGA), rs11649255 in AXIN1 [in almost complete linkage disequilibrium (LD) with rs11644916], was associated with shorter OS (HR, 2.24, P = 0.0096). Using rs11648673 in AXIN1 (in very high LD with rs11644916 and with functional evidence), luciferase activity in three colorectal cancer cell lines was reduced. Conclusions: This is the first large genome-wide association study ever conducted in patients with mCRC treated with first-line standard treatment in a randomized phase III trial. A common SNP in AXIN1 conferred worse OS and the effect was replicated in TCGA. Further studies in colorectal cancer experimental models are required.
Ultrathin and Robust Hydrogel Coatings on Cardiovascular Medical Devices to Mitigate Thromboembolic and Infectious Complications
Parada, German Alberto , Yu, Yan , Riley, William B., Lojovich, Sarah, Tshikudi, Diane M. , Ling, Qing , Zhang, Yefang, Ling, Lei , Yang, Yueying , Nadkarni, Seemantini K. , Nabzdyk, Christoph S. , Nabzdyk, Christoph , Wang, Jiaxin , Zhao, Xuanhe

Mayo Clinic

Advanced Healthcare Materials | September 17, 2020 | Volume: 9 | Issue: 20 | Pages: No page available

10.1002/adhm.202001116 | PMID 32940970 Get It

AbstractThromboembolic and infectious complications stemming from the use of cardiovascular medical devices are still common and result in significant morbidity and mortality. There is no strategy to date that effectively addresses both challenges at the same time. Various surface modification strategies (e.g., silver, heparin, and liquid‐impregnated surfaces) are proposed yet each has several limitations and shortcomings. Here, it is shown that the incorporation of an ultrathin and mechanically robust hydrogel layer reduces bacterial adhesion to medical‐grade tubing by 95%. It is additionally demonstrated, through a combination of in vitro and in vivo tests, that the hydrogel layer significantly reduces the formation and adhesion of blood clots to the tubing without affecting the blood's intrinsic clotting ability. The adhesion of clots to the tubing walls is reduced by over 90% (in vitro model), which results in an ≈60% increase in the device occlusion time (time before closure due to clot formation) in an in vivo porcine model. The advantageous properties of this passive coating make it a promising surface material candidate for medical devices interfacing with blood.
Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy
Ahuja, Abhimanyu S. , Selvam, Pavalan , Vadlamudi, Charitha , Chopra, Hayley, Richter, John E. , Macklin, Sarah , Samreen, Ayesha , Helmi, Haytham , Mohammaad, Ahmed N., Hines, Stephanie L., Davila, Maria C., Caulfield, Thomas R. , Hines, Stephanie, Caulfield, Thomas R , Samreen, Ayesha , Ahuja, Abhimanyu , Atwal, Paldeep S

Mayo Clinic

Ophthalmic Genetics | September 17, 2020 | Volume: 41 | Issue: 6 | Pages: 563-569

10.1080/13816810.2020.1814344 | PMID 32940104 Get It